Advanced Machine Intelligence Labs, founded by Yann LeCun and other ex-Meta researchers, has raised more than $1 billion from investors. By Cade Metz Reporting from San Francisco Late last year, Yann ...
An AI agent reads its own source code, forms a hypothesis for improvement (such as changing a learning rate or an architecture depth), modifies the code, runs the experiment, and evaluates the results ...
Artificial intelligence (AI) is transforming the way scientists discover and design new materials. In a specially invited review published in Angewandte Chemie International Edition, Tohoku University ...
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...
Researchers used AI and deep learning to find a link between brain structure and navigation skills but found no measurable ...
Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining ...
Mindmachines.com, a leading distributor of brainwave entrainment technology, is emphasizing the growing role of advanced neurotechnology in helping individuals achieve deeper meditative states and ...
U.S. Army Soldiers, assigned to the 6th Squadron, 8th Cavalry Regiment, and the Artificial Intelligence Integration Center, conduct drone test flights and software troubleshooting during Allied Spirit ...
WASHINGTON – The U.S. Army has established a new career pathway for officers to specialize in artificial intelligence and machine learning (AI/ML), formally designating the 49B AI/ML Officer as an ...
Yann LeCun at Viva Technology conference at Parc des Expositions Porte de Versailles on June 14, 2023 in Paris, France. Yann LeCun is one of the giants in artificial intelligence. Known as a founding ...
Machine learning is transforming many scientific fields, including computational materials science. For about two decades, scientists have been using it to make accurate yet inexpensive calculations ...
Patients with locally advanced non-small cell lung cancer (NSCLC) who undergo concurrent chemoradiotherapy (CCRT) followed by consolidation immunotherapy show heterogeneous survival outcomes. Accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results